Advertisement

BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 600x60px
Document › Details

Kinaxo Biotechnologies GmbH. (5/9/08). "Press Release: Kinaxo Biotechnologies Enters Agreement with Onconova Therapeutics Inc.". Martinsried.

Organisation Organisation Kinaxo Biotechnologies GmbH
  Group Evotec (Group)
Products Product cancer drug
  Product 2 Cellular Target Profiling technology (Kinaxo)
Index term Index term Onconova Therapeutics–Kinaxo: drug development services, 200805– service use of Cellular Target Profiling Technology for small-molecule cancer drugs
     


KINAXO Biotechnologies announced today a cooperation between Oncovova Therapeutics Inc, Newtown, PA, USA (www.onconova.com) and KINAXO Biotechnologies. Onconova Therapeutics is a clinical stage research and development company focused on development of its novel small molecule products for cancer therapy and radiation protection. KINAXO will apply its Cellular Target Profiling Technology to support Onconova's clinical development of cancer drugs.

KINAXO's Cellular Target Profiling Technology includes identification of a compound's cellular target profile as well as affinity data for targets identified from cell lines. It utilizes proprietary chemical proteomics technologies combined with state-of-the-art mass spectrometry to identify and characterize a drug candidate's native molecular targets in cell lines and tissue samples. The affinity is determined using a free, unmodified compound. This service enables pharmaceutical and biotechnology companies to make more informed decisions on which drug candidates to progress into advanced pre-clinical or clinical development.


About KINAXO

KINAXO Biotechnologies is a privately-held biotechnology company based in Munich/Martinsried, Germany. We support pharmaceutical and biotechnology companies in their development and optimization of drugs.

As a spin-off of the Max-Planck Institute of Biochemistry in Martinsried, KINAXO offers extensive experience and a proven track record in cellular kinase profiling with several pharmaceutical and biotechnology company collaborations ongoing, i.e. UCB Pharma, Johnson & Johnson and Takeda. KINAXO is financed by European investors BioM, High-Tech Gründerfonds, KfW, Max Planck Society, and Mountain Partners.

   
Record changed: 2016-03-19

Advertisement

Picture AB Sciex Berliner LCMSMS Symposium 2017 Middle 600x60px

More documents for Evotec (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture AB Sciex Berliner LCMSMS Symposium 2017 Middle 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 120x180px Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 120x180px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px